Pheochromocytoma other diagnostic studies: Difference between revisions
Jump to navigation
Jump to search
Irfan Dotani (talk | contribs) No edit summary |
Ifrah Fatima (talk | contribs) |
||
| (8 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Pheochromocytoma}} | {{Pheochromocytoma}} | ||
{{CMG}}; {{AE}} {{AAM}} | {{CMG}}; {{AE}} {{AAM}} {{MAD}} | ||
{{ | |||
==Overview== | ==Overview== | ||
[[Clonidine#Clonidine suppression test|Clonidine suppression test]] may be used in the diagnosis of pheochromocytoma. | [[Clonidine#Clonidine suppression test|Clonidine suppression test]] may be used in the diagnosis of pheochromocytoma. | ||
==Other Diagnostic Studies== | ==Other Diagnostic Studies== | ||
*[[Clonidine#Clonidine suppression test|Clonidine suppression test]] | Other diagnostic studies for [[pheochromocytoma]] include: | ||
*[[Clonidine]] is a centrally-acting alpha-2 agonist | *[[Clonidine#Clonidine suppression test|Clonidine suppression test]], which demonstrates: <ref name="pmid26335433">{{cite journal| author=Goupil R, Fountoulakis S, Gordon RD, Stowasser M| title=Urinary clonidine suppression testing for the diagnosis of pheochromocytoma. | journal=J Hypertens | year= 2015 | volume= 33 | issue= 11 | pages= 2286-93 | pmid=26335433 | doi=10.1097/HJH.0000000000000705 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26335433 }}</ref> | ||
**Lack of a response to clonidine (no reduction in [[catecholamine]] levels after test) | |||
*Healthy [[adrenal medulla]] will respond to the | *[[Clonidine]] is a centrally-acting [[Alpha-2 receptor|alpha-2 agonist]] which mimics [[catecholamines]] in the [[brain]] and reduces the activity of the [[sympathetic nerves]] controlling the [[adrenal medulla]]. | ||
*Healthy [[adrenal medulla]] will respond to the [[clonidine]] suppression test by reducing [[catecholamine]] production. | |||
==References== | ==References== | ||
| Line 19: | Line 15: | ||
[[Category:Endocrinology]] | [[Category:Endocrinology]] | ||
Latest revision as of 22:04, 28 July 2020
|
Pheochromocytoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Pheochromocytoma other diagnostic studies On the Web |
|
American Roentgen Ray Society Images of Pheochromocytoma other diagnostic studies |
|
Risk calculators and risk factors for Pheochromocytoma other diagnostic studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmad Al Maradni, M.D. [2] Mohammed Abdelwahed M.D[3]
Overview
Clonidine suppression test may be used in the diagnosis of pheochromocytoma.
Other Diagnostic Studies
Other diagnostic studies for pheochromocytoma include:
- Clonidine suppression test, which demonstrates: [1]
- Lack of a response to clonidine (no reduction in catecholamine levels after test)
- Clonidine is a centrally-acting alpha-2 agonist which mimics catecholamines in the brain and reduces the activity of the sympathetic nerves controlling the adrenal medulla.
- Healthy adrenal medulla will respond to the clonidine suppression test by reducing catecholamine production.
References
- ↑ Goupil R, Fountoulakis S, Gordon RD, Stowasser M (2015). "Urinary clonidine suppression testing for the diagnosis of pheochromocytoma". J Hypertens. 33 (11): 2286–93. doi:10.1097/HJH.0000000000000705. PMID 26335433.